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Abstract
Purpose The aim of this study was to determine which genes
and gene pathways are differentially expressed when compar-
ing human blastocysts with cleavage-stage embryos.
Methods We individually assessed gene expression in preim-
plantation human embryos at cleavage (n=3) and blastocyst
(n=3) stages. Gene expression patterns were then validated in
publically available datasets and then independently validated
in vitro with additional human embryos using TaqMan gene
expression assays. Immunolocalization studies were conduct-
ed to identify protein expression in intact blastocyst-stage
embryos.
Results Compared to cleavage-stage embryos, blastocyst-
stage embryos differentially expressed 51 genes (p<0.001),
with overrepresentation in amoebiasis pathways and pathways
in cancer. Of these 51 genes, 21 were found to be indepen-
dently validated in a separate, publically available dataset,
with a substantial agreement with our initial findings
(κ=0.8). In an independent set of cleavage- and blastocyst-
stage embryos, we validated that six of eight tested genes were
different ia l ly expressed (p < 0.05) by RT-qPCR.
Immunofluorescence studies documented the presence of
two studied proteins in the trophectoderm of blastocyst-stage
embryos.
Conclusions Differentially expressed genes may be implicat-
ed in the invasion and proliferation of the early embryo. Our
research highlights specific genes that may be further studied
for their role in the implantation process and additionally
raises questions about localized gene and/or protein expres-
sion in the trophectoderm, which could affect protocols for,
and interpretation of, trophectoderm biopsies performed in
in vitro fertilization cycles.
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Introduction
Human embryonic genome activation begins between the
two- and eight-cell stages [1, 2]. While stored maternally de-
rived oocyte RNA transcripts are necessary for the nascent
embryo to complete the first mitotic divisions, continued em-
bryonic development is predicated on the expression of em-
bryonic genes which lead to blastocyst formation and, ulti-
mately, result in successful implantation.
Our understanding of genes critical to embryonic implan-
tation remains limited. Early studies of gene expression in
preimplantation embryos examined differential expression as
early as prefertilization oocytes through as late as blastocyst-
stage embryos and even embryonic stem cells [3, 4]. These
studies have identified genes important in the transition from
maternal to embryonic genome expression [2, 5–7], including
those involved in DNA repair [8], cellular growth [9],
Capsule There are differentially expressed genes in human blastocyst-
stage embryos compared with cleavage-stage embryos, and these genes
are involved in cellular movement and cancer pathways.
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trophectoderm development [10], as well as novel RNA se-
quences never seen in other human cell types [11]. However,
such large profiling studies often make very broad compari-
sons with very different cell types (such as oocytes with
blastocyst-stage embryos or cleavage-stage embryos with
established human embryonic stem cell lines). Additionally,
the abundance of raw data generated in such studies makes it
difficult to meaningfully interpret all data in order to more
deeply understand physiologic processes occurring in be-
tween these points in development. Specifically, these studies
have not thoroughly examined the role of gene expression in
blastocyst formation and function, with arguably the most
important of these functions being successful implantation
and pregnancy.
Here, we identify genes differentially expressed in human
blastocyst-stage embryos as compared to cleavage-stage em-
bryos and timepoints chosen for the purpose of identifying
changes occurring after the onset of embryonic genome ex-
pression. We suggest that genes with differential expression in
blastocyst-stage (as compared to cleavage-stage) embryos are
likely to have significance both in the structure and the func-
tion of the blastocyst. The differentially expressed embryonic
genes reported here, validated both in silico and in vitro, are
associated with cellular movement and cancer pathways, both
with shared characteristics of an implanting and invading em-
bryo. Using immunofluorescence, we localized two of these
proteins, S100A14 and S100A16, to the trophectoderm.
Materials and methods
Acquisition and culture of embryos
Approval from the University of Iowa’s Institutional Review
Board (#200804752) was obtained prior to the performance of
all experiments. Embryos used in our study had been specif-
ically donated for use in research (#200109085) by patients
who had undergone in vitro fertilization treatment, using ei-
ther conventional insemination or intracytoplasmic sperm in-
jection, and had supernumerary zygotes cryopreserved at the
pronuclear stage. These embryos were cryopreserved and
thawed as described previously [12]. For all experiments, em-
bryos (n=136) were cultured using commercially available
embryo culture media supplemented with 20 % Quinns
Advantage Serum Protein Substitute (Cooper Surgical) in
5.5–6.0 % CO2 in air at 37 °C. Embryos designated for study
on the third day post fertilization (D3) were cultured for 48 h,
whereas embryos designated for study on the fifth day post
fertilization (D5) were cultured for 96 h. All D3 embryos
included in the studies (n=27) exhibited 6–10 blastomeres
with ≤20 % fragmentation, while D5 blastocyst-stage embry-
os selected for study (n=27) were blastocysts with at least an
BA^ or BB^ rating for both the trophectoderm and inner cell
mass scores, as graded using the classification system outlined
by Gardner and Schoolcraft [13].
Discovery via microarray: hybridization, microarray
construction, and quality control
For the initial discovery set, RNA was isolated from each of
six human embryos (three D3 and three D5, processed indi-
vidually) using the RNeasy kit (Qiagen) according to the man-
ufacturer’s protocol. Total RNA was converted to signaling
pathway impact analysis (SPIA)-amplified complementary
DNA (cDNA) using the WT-Ovat ion Pico RNA
Amplification System, v1 (NuGEN Technologies) according
to the manufacturer’s recommended protocol. The SPIA-
amplified cDNA product was purified through a Qiagen
QIAquick PCR Purification column (Qiagen) according to
modifications from NuGEN. SPIA-amplified DNA (4 μg)
was used to generate sulfotransferase (ST) cDNA using the
WT-Ovation Exon Module v1 (NuGEN Technologies) and
cleaned with the Qiagen column as above. This product
(5 μg) was fragmented (average fragment size = 85 bases)
and biotin-labeled using the NuGEN FL-Ovation cDNA
Biotin Module, v2 (NuGEN Technologies) as per the manu-
facturer’s recommended protocol. The resulting biotin-labeled
cDNA was mixed with Affymetrix eukaryotic hybridization
buffer, placed onto Affymetrix Human Exon 1.0 ST arrays,
and incubated at 45 °C for 18 h with 60 rpm rotation in an
Affymetrix GeneChip Hybridization Oven, model 640.
Following hybridization, the arrays were washed, stained with
streptavidin-phycoerythrin (Molecular Probes, Inc.), and
signal-amplified with antistreptavidin antibody (Vector
Laboratories, Inc.) using the Affymetrix Fluidics Station,
model 450. Arrays were scanned with the Affymetrix scanner
(model 3000) with 7G upgrade, and data were collected using
the GeneChip operating software (GCOS v3.1).
Gene expression and pathway analysis
CEL file output from Affymetrix microarray processing was
uploaded, normalized within each array using endogenous
expression and array exposure controls, and filtered if exces-
sive missing values or outliers were detected. Probe set sum-
maries and annotations were abstracted from standard anno-
tation files specific to Affymetrix Human Exon 1.0 ST arrays
(http://www.affymetrix.com/support/technical/byproduct.
affx?product=huexon-st). Genes were considered to be
differentially expressed when differences achieved a
univariate significance level of p <0.001, to avoid false-
positive results due to multiple comparisons. To identify over-
represented and significant pathways among the selected sig-
nificant genes in the Kyoto Encyclopedia of Genes and
Genomes (KEGG) [14], we used MetaCore (GeneGo, Inc.)
and clusterProfiler, an R statistical package. Both are
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integrated and curated knowledge-based platforms for path-
way analysis. To include all possible overrepresented path-
ways, the enrichment analysis included all differentially
expressed genes significant at a p value <0.01, with a false
discovery rate (FDR) of <0.1 (q value).
In silico validation and analysis
A search of the Gene Expression Omnibus (GEO, www.ncbi.
nlm.nih.gov/geo) database was conducted to identify publicly
available datasets of microarray gene expression experiments
previously performed with human preimplantation embryos.
This search identified a similarly designed study, with array
data submitted to GEO under the accession number GSE18290
[4]. In that study, total RNA from preimplantation embryos
(from single cell to blastocyst stage) was extracted, amplified,
and hybridized onto Affymetrix U133 Plus 2.0 Arrays
(Affymetrix). From the 52 datasets submitted by these
investigators (16 bovine, 18 mouse, and 18 human), we used
those six representing the embryos of interest for our study (all
three human embryos at the eight-cell stage and all three human
embryos at the blastocyst stage).
Gene expression data were analyzed using comparisons
identical to our original discovery set. Only genes identified
as significant in the discovery set were used for validations; a
two-sample t test, with significance at p <0.05, was used for
comparisons. For comparisons, we used the Biometric
Research Branch (BRB) ArrayTools software suite (version
2.13.2 for X64 systems), an integrated package for visualiza-
tion and statistical analysis utilizing Microsoft Excel at the
front end, with tools developed in the R statistical system.
In vitro validation and analysis
Eight genes of interest, based on potential mechanism and fold
change, were selected for validation in vitro using reverse
transcription quantitative PCR (RT-qPCR). RNAwas purified
from individual embryos (six D3 embryos and six D5 embry-
os for each RT-qPCR assay) using the PicoPure RNA
Isolation kit (Arcturus) according to the protocol with the
addition of a DNase I digest step (#79254, Qiagen) prior to
wash buffer 2 and a final elution volume of 20 μL. The eluent
was concentrated into a volume of 10 μL by SpeedVac
(Thermo Fisher). This method of embryonic RNA isolation
was confirmed by RT-qPCR assay for the embryo-specific
genes OCT4 and NANOG (data not shown). Reverse tran-
scription was performed using a High Capacity cDNA
Reverse Transcription Kit (#4368814, Life Technologies).
Gene-specific RT-qPCR assays were carried out in triplicate
using prevalidated TaqMan Assays (Life Technologies). Each
embryo had sufficient RNA to be used for two gene-specific
assays plus control. No total RNA amplifications were carried
out in order to avoid the possibility of introducing amplifica-
tion bias into the study.
Immunofluorescence
Previously cryopreserved blastocyst-stage embryos were
thawed, allowed to re-expand for 4 h in culture media, and
washed in a solution of Gibco Dulbecco’s phosphate-buffered
saline (PBS, Life Technologies) with added 1 mg/mL polyvi-
nylpyrrolidone (PVP, Sigma). Embryos were fixed with 4 %
paraformaldehyde for 30 min at room temperature, washed
three times in PVP/PBS, and permeabilized in 0.2 % Triton
X-100 in PVP/PBS for 30 min at room temperature. Blocking
was performed overnight at 4 °C using 10 % normal goat sera
(G-9023, Sigma) in PVP/PBS. The following primary anti-
bodies were prepared in 10 % normal goat sera: rabbit anti-
S100A14 IgG at 1/200 dilution (10489-1-AP, Proteintech) and
rabbit anti-S100A16 IgG at 1/100 dilution (11456-1-AP,
Proteintech). Embryos were incubated in one of these two
antibodies, no-antibody control (10 % normal goat sera), or
normal rabbit IgG (011-000-003, Jackson Immuno Research)
prepared to equal concentration as the antibodies (for anti-
S100A14 control, 1.6 μg/mL; for anti-S100A16 control,
2.5 μg/mL). Embryos were incubated overnight at 4 °C,
washed three times in PVP/PBS, and incubated in F(ab’)2-
goat anti-rabbit IgG (H + L) secondary antibody, Alexa
Fluor® 488 conjugate (A11070, Life Technologies), diluted
1/500 in 10 % normal goat sera, for 4 h at room temperature.
Embryos were washed in PVP/PBS, put through a dilution
series of 25 %, 50 %, 75 %, and 100 % Vectashield with 4′,
6-diamidino-2-phenylindole (DAPI) (Life Technologies) in
PVP/PBS as described elsewhere [15], and mounted in a
hanging-drop slide to preserve blastocyst structure. Embryos
were imaged using a Zeiss LSM 710 confocal laser scanning
microscope (Zeiss, Germany).
Statistical analysis
For Affymetrix arrays in the discovery set, two-sample f tests
were used to determine differential gene expression with a
univariate significance level of p <0.001. For in silico valida-
tion, a two-sample t test was used to determine the signifi-
cance of gene expression, with a significance set at p <0.05.
The agreement between differentially expressed genes in both
sets (discovery and validation in silico) was evaluated by
Cohen’s kappa. Test κ values are interpreted as <0 (no agree-
ment), 0–0.20 (slight), 0.21–0.40 (fair), 0.41–0.60 (moderate),
0.61–0.80 (substantial or good), and 0.81–1 (almost perfect
agreement). For in vitro validation, all raw expression data (Ct
values) were normalized (ΔCt) using the endogenous RNA
control 18S rRNA. Gene expression differences between D3
and D5 embryos were assessed as fold change via the conven-
tional ΔΔCt method [16, 17]. Statistical significance was
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evaluated with a two-sample t test with unequal variances,
with p values <0.05 considered significant.
Results
Discovery of differentially expressed genes
Affymetrix microarray analysis of three good-quality D3 em-
bryos and three good-quality D5 embryos identified differen-
tial expression of 51 genes. Of these, 31 were overexpressed
in D5 blastocyst-stage embryos and 20 were underexpressed
(Supplemental Table 1). Pathway analyses of these genes
using KEGG found five overrepresented pathways including
amoebiasis and cancer (Table 1).
In silico validation
We identified a similar study of human preimplantation em-
bryos through the NCBI Gene Expression Omnibus and com-
pared our 51 differentially expressed genes with 47 that were
available for comparison. Of these, 23 genes were statistically
significant in both sets, and 21 of 23 displayed expression
congruent with our original findings (Table 2). This represents
a κ value equal to 0.8 (substantial or good correlation).
In vitro validation
Based on potential biological significance in embryo adhesion
and invasion as well degree of fold change, we chose eight
genes to validate in vitro, using an independent panel of six
D3 and six D5 embryos for each gene assay. Among the eight
chosen genes, all displayed differential expression patterns
consistent with the original array and in silico validation re-
sults and six achieved statistical significance (Table 2). The
overall correlation between fold changes from our Affymetrix
arrays and TaqMan gene-specific assays was r = 0.92
(p=0.006; df=6).
Immunofluorescence and localization of S100 proteins
The two genes with the greatest differential expression
levels, S100A16 and S100A14, were selected for localiza-
tion studies. Using confocal microscopy, we observed that
S100A14 is exclusively localized to the trophectoderm
cells and is absent in the inner cell mass (Fig. 1).
Further, the intensity of the staining appears greater in
trophectoderm cells nearer to the pole closest to the
trophectoderm hatching point (Fig. 1e) but appears to be
present in all cells. S100A16 was also seen in the
trophectoderm (Fig. 2), was more finely distributed in ex-
pression, and was lower in intensity in the inner cell mass
(Fig. 2d). Expression of this protein appeared to be limited
to some nuclei and also polarized to one quadrant of the
trophectoderm close to the trophectoderm hatching point
(Fig. 2e).
Discussion
Our study shows that there are numerous differentially
expressed genes in human blastocyst-stage embryos com-
pared with cleavage-stage embryos. These genes are involved
in cellular movement and cancer pathways and are likely
Table 1 Pathways enriched by genes differentially expressed in the discovery set
KEGG 
entry





DLAT/ ADH5/ PFKP/ PGM1/ 
PGK1/ PDHB
hsa04662
B cell receptor 
signaling pathway
0.008 0.04
CD81/ IFITM1/ AKT3/ RAF1/ 
INPP5D/ PIK3R3
hsa05146 Amoebiasis 0.039 0.09






CALM3/ AKT3/ RAF1/ INPP5D/ 
PIK3R3/ PRKAR2A/ PPP1R3A
hsa05200 Pathways in cancer 0.044 0.09
JUP/ TPM3/ FN1/ AKT3/ FZD5/ 
RAF1/ LAMA1/ PIK3R3/ APC/ 
FGF13/ NCOA4/ NFKB2/ 
LAMA4
a Green gene symbols indicate decreased expression in D5 embryos compared with D3 embryos, whereas 
red gene symbols are genes with increased expression in D5 embryos compared with D3 embryos.
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necessary for embryo adhesion and implantation. We re-
port here for the first time that S100A14 and S100A16,
which have been previously shown to be associated with
cancer cell invasion [18–22], are abundant in blastocysts
and appear to be localized to the trophectoderm, consistent
with a role in the invasiveness of the trophoblast during
implantation.
In 2009, Zhang and colleagues reported that human em-
bryo preimplantation development could be divided into two
transitions: early versus late maternal genomic expression
(from oocyte to four-cell embryo) and embryonic genomic
expression (eight-cell embryo to blastocyst stage), with most
differentially expressed embryonic genes involved in meta-
bolic processes [7]. Similarly, we identified increased expres-
sion of embryonic genes overrepresented in pathways related
to glycolysis and dynamic expression of genes in insulin
signaling, and both pathways are important to the developing
embryo. Additionally, we are the first to report differential
expression of embryonic genes involved in pathways related
to amoebiasis and cancer, processes likely important for
rapid cell division, movement, adhesion, and invasion,
all which must occur during early embryo development
and implantation.
Twenty-one of our original discovery set of 51 differential-
ly expressed genes were validated in silico by comparison to
Affymetrix data published by Xie and colleagues, with global
transcriptional similarities noted among bovine, murine, and
human embryos, suggesting their evolutionary importance
[4]. We chose to validate eight of our genes further via RT-
qPCR and found that all eight exhibited changes in a manner
consistent with the in silico validations and, of these, six were
statistically significant in our validation assays.






In silicoa In vitro






MNS1 Down Down –3.65
RNF168 Down Down –3.60
FN1 Down Down –3.22
SLC3A1 Down Down –2.66
SERPINE2 Down Down Down –2.41 –3.87 0.188
DDX59 Down Down –2.10
C10orf68 Down Up –1.81
GALNT6 Up Up Up 1.35 11.02 0.039
TMCC3 Up Up 1.55
SPAG11B Up Down 1.80
HARS2 Up Up 1.97
JUP Up Up Up 1.97 7.76 0.208
FARSA Up Up 2.07
CLDN4 Up Up Up 3.56 55.86 0.049
SLC4A11 Up Up 3.65
TUBB2B Up Up 3.80
TFCP2L1 Up Up Up 4.17 14.60 0.002
ZDHHC9 Up Up 4.72
GDPD2 Up Up Up 5.47 270.36 <0.001
ANPEP Up Up 7.31
DEPDC1 Up Up 9.12
S100A16 Up Up Up 14.44 305.50 <0.001
S100A14 Up Up Up 18.04 472.51 <0.001
a κ= 0.8 between the discovery set and in silico validation
b r= 0.92 between the fold change from discovery set and the fold change from in vitro validation (p= 0.006; df= 6)
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Polypeptide N-acetylgalactosaminyltransferase 6 (known
as GALNT6) is a member of the GALNT family of proteins
which begins mucin-type O-linked protein glycosylation
[23]. GALNT6 may be involved with the synthesis of
oncofetal fibronectin, which is secreted by cultured tropho-
blasts [24] and may potentially facilitate embryo adhesion to
the uterine endometrium [25]. Additionally, alterations in
mucin O-glycosylation are implicated in malignant transfor-
mation of some carcinomas; GALNT6 expression has been
found to be greater in breast cancer tissue compared with
normal breast tissue [26] and was correlated with venous
invasion in gastric cancers [27].
Claudin 4 is a member of the claudin protein family that
plays a ubiquitous and integral role in the formation of gap
junctions. Claudin 4 is necessary for appropriate structure and
function of reproductive tissues, such as the blood-testis bar-
rier [28], and its messenger RNA (mRNA) levels in the luteal-
phase endometrium have been correlatedwith pregnancy [29].
Mouse embryos cultured in the presence of Clostridium
perfringens enterotoxin inhibitory to claudin 4 failed to form
a mature blastocele cavity, demonstrating the importance of
claudin 4 in the normal formation of blastocysts [30]. In ad-
dition to tight junctions, claudin 4 has been shown to be lo-
calized in cellular projections of breast cancer cells, where it
promotes cellular motility in a wound-healing model [31].
Thus, its increased level in our blastocyst-stage embryos is
suggestive of not only its importance in blastocyst formation
but could be potentially involved in uterine implantation.
Perhaps the most important finding reported here is the
300–400-fold increase in the mRNA expression of two S100
Fig. 1 Immunolocalization of
S100A14 to the trophectoderm of
human blastocyst-stage embryos.
Representative images taken for
immunofluorescence with DAPI
for nuclear stain. a No primary
antibody, b rabbit IgG control, c
1:100 anti-S100A14 (bright-field
overlay), d Alexa Fluor® 488
only, and e 3D reconstruction (Z
stack) of S100A14 with embryo
hatching at approximately 4
o’clock
Fig. 2 Immunolocalization of
S100A16 suggesting embryo
polarity and expression near the
hatching portion of human
blastocyst-stage embryos.
Representative images taken for
immunofluorescence with DAPI
for nuclear stain. a No primary
antibody, b rabbit IgG control, c
1:100 anti-S100A16 (bright-field
overlay), d Alexa Fluor® 488
only, and e 3D reconstruction (Z
stack) of S100A16 with embryo
hatching at approximately 9
o’clock
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calcium-binding proteins A16 and A14, with immunofluores-
cence documenting the predominant expression of these two
proteins within the trophectoderm of the human blastocyst.
S100A14, a 104-amino acid protein with calcium-binding
motifs, was shown to be overexpressed in 10 tumor types
(including ovary, breast, and uterus), but not present in normal
placenta [32]. Its expression has been detected in the circulat-
ing stem cells of patients with advanced metastatic colorectal
and breast cancer [18]. S100A14 was also associated with the
capability of breast cancer cells to produce distant metastases
[19] and with increased motility and invasiveness of malig-
nant cells in colon cancer cell lines [20]. Further, it has been
shown to co-localize with HER2, a known EGFR protein
associated with more aggressive breast cancers [33]. We
found that S100A14 localizes to the trophectoderm of
blastocyst-stage embryos with a slightly greater expression
in the pole of the blastocyst hatching through the zona pel-
lucida (Fig. 1e). S100A14 overexpression is known to mod-
ulate expression of matrix metalloproteinase 2 (MMP2), a
key factor in the implantation process [20]. Our RT-qPCR
validation and immunofluorescence localization to the
trophectoderm, coupled with S100A14’s function in aggres-
sive cancer mechanisms and regulation of expression of a
key gene, MMP2, involved in implantation suggests that
S100A14’s role in the implantation process needs to be fur-
ther examined.
S100A16, also a calcium-binding protein, is mainly local-
ized in nucleoli, with nucleocystoplasmic transport stimulated
by high levels of intracellular calcium levels [34]. It is co-
expressed with S100A14 in oral squamous cell cancer, breast
cancer, and several cancer cell lines [21, 22]. Interestingly, we
noted differences in signal intensity in our immunofluores-
cence studies on S100A16 suggestive of embryo polarity as
we captured more diffuse signal in the quadrant of the
trophectoderm near the hatching point. For the remainder of
the trophectoderm, only the nucleoli appear to be positive for
S100A16 (Fig. 2e). Previous studies have shown that cellular
stretch can cause intracellular calcium influx via stretch-
activated calcium channels [35]. If calcium influx is occurring
at the embryo hatching point, then this would explain the more
diffuse localization of S100A16 outside the nucleoli and into
the cytoplasm, as seen with calcium influx within mouse glial
cells [34].
We also examined potential roles for transcription
factor CP2-like 1 (TFCP2L1) and glycerophophodiester
phosphodiesterase domain containing 2 (GDPD2); how-
ever, since these genes have not yet been well described
in the literature, we were unable to draw meaningful
conclusions about their potential involvement in embryonic
development.
The work presented here raises questions to be answered in
subsequent studies. Several papers have suggested that bovine
embryos, having similar gene expression profiles to humans,
are good models for human embryonic development and have
shown differential gene expression at different stages of pre-
implantation development [36–38]. In examining these re-
ports, we found that 15 of our 51 differentially expressed
genes were differentially expressed in at least one of those
studies, and five of those were among the six genes we vali-
dated by RT-qPCR (CLDN4, TFCP2L1, GDPD2, S100A16,
and S100A14). Additionally, the two S100 proteins were iden-
tified by Jiang et al. [37] as being represented in Gene
Ontology pathways of cellular motility, migration, and che-
motaxis, which is consistent with our discovery set pathway
analyses. As is common inmost other fields of study, critically
important genes may overlap in multiple putative pathways
(Table 1), which may affect their degree of overrepresentation.
Recognizing the importance of embryonic research and scar-
city of human embryos available, we suggest a future study of
these genes, and others, which could be performed in bovine
preimplantation embryos, to include protein expression and
localization studies as well to independently validate these
pathways described.
Our studies were carried out exclusively on previously
cryopreserved embryos, and there may be differences in gene
expression in fresh versus cryopreserved embryos. However,
cryopreserved embryos have been shown to be a more con-
sistent, reliable source for gene expression studies as com-
pared with fresh embryos [39]. Differences in gene expression
can also be associated with different culture systems, as has
been previously shown in other animal species [40, 41] and,
recently, in human preimplantation embryos [42]. Given that
we were able to validate our initial findings in a dataset ob-
tained from embryos cultured in a different system, we sug-
gest that the gene expression patterns we have observed may
be important enough to be conserved in the embryo’s devel-
opmental processes independent of culture environment.
Finally, while genes expressed in preimplantation embryonic
development may be important in processes leading to preg-
nancies and live births, our results cannot yet be matched with
these clinically important outcomes. We hope, however, that
with this knowledge, we will be able to characterize genetic
signatures, via trophectoderm biopsies obtained during preim-
plantation genetic screening, that are associated with intrauter-
ine pregnancies and live births. Eventually, such information
may have an important translational value by incorporating
this information into both invasive and non-invasive criteria
for embryo selection, beyond just chromosome number, thus
allowing for selection of euploid embryos with the best chance
of implantation.
In summary, we present a panel of genes differentially
expressed in blastocyst-stage embryos relative to cleavage-
stage embryos. Further, we define their association with path-
ways related to cellular movement and cancer mechanisms
and localize two of the expressed proteins to the
trophectoderm. We now open a window of opportunity for
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clinicians and basic scientists to better understand the molec-
ular mechanisms in determining embryonic competence and
potentially develop means to improve in vitro fertilization
practices by selecting the most capable embryos for transfer.
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